DNA adducts in human tissues: Biomarkers of exposure to carcinogens in tobacco smoke

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 453-458

  Phillips, David H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

32P postlabeling; Aromatic amines; Cancer; Human biomonitoring; Immunoassay; Mass spectrometry; Nitrosamines; Polycyclic aromatic hydrocarbons; Tobacco carcinogens

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; TOBACCO SMOKE;

BIOLOGICAL MONITORING; BLADDER; BRONCHUS; CANCER; CANCER MORTALITY; CONFERENCE PAPER; DIET; DNA ADDUCT; DNA DAMAGE; FLUORESCENCE SPECTROSCOPY; HUMAN; IMMUNOASSAY; LARYNX; LEUKOCYTE; LUNG; MASS SPECTROMETRY; MOUTH MUCOSA; PRIORITY JOURNAL; SMOKING; UTERINE CERVIX;

EID: 0029886862     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3453     Document Type: Conference Paper

References (55)

1. Bartecchi CE, MacKenzie TD, Schrier RW. The global tobacco epidemic. Sci Am 272:44-51 (1995).
2. IARC. Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol 38. Lyon:International Agency for Research on Cancer, 1986.
3. IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol 37: Tobacco Habits Other than Smoking; Betel-quid and Areca-nut Chewing; and Some Related Nitrosamines. Lyon:International Agency for Research on Cancer, 1985.
4. Hoffmann D, Hecht SS. Advances in tobacco carcinogenesis. In: Chemical Carcinogenesis and Mutagenesis I (Cooper CS, Grover PL, eds). Berlin:Springer-Verlag, 1990;63-102.
5. Phillips DH, Farmer PB. Protein and DNA adducts as biomarkers of exposure to environmental mutagens. In: Environmental Mutagenesis (Phillips DH, Venitt S, eds). Oxford:Bios, 1995;367-395.
6. Poirier MC. Development of immunoassays for the detection of carcinogen-DNA adducts. In: Molecular Dosimetry and Human Cancer (Groopman JD, Skipper PL, eds). Boca Raton, FL:CRC Press, 1991;211-229.
7. 32P-postlabelling assay. Carcinogenesis 13:1053-1074 (1992).
8. Weston A. Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat Res 288:19-29 (1993).
9. Phillips DH, Hewer A, Martin CN, Garner RC, King MM. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 336:790-792 (1988).
10. 32P-postlabelling assay. J Natl Cancer Inst 81:341-347 (1989).
11. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 46:569-575 (1990).
12. Geneste O, Camus A-M, Castegnaro M, Petruzzelli S, Macchiarini P, Angeletti CA, Giuntini C, Bartsch H. Comparison of pulmonary DNA adduct levels, measured by P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis 12:1301-1305 (1991).
13. Dunn BP, Vedal S, San RHC, Kwan W-F, Nelems B, Enarson DA, Stich HF. DNA adducts in bronchial biopsies. Int J Cancer 48:485-492 (1991).
14. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54:5801-5803 (1994).
15. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at greater risk for lung cancer than male smokers? Am J Epidemiol 138:281-293 (1993).
16. Zang EA, Wynder EL. Cumulative tar exposure: a new index for estimating lung cancer risk among cigarette smokers. Cancer 70:69-76 (1992).
17. van Schooten FJ, Hillebrand MJX, van Leeuwen FE, Lutgerink JT, van Zandwijk N, Jansen HM, Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 11:1677-1681 (1990).
18. Weston A, Bowman ED. Fluorescence detection of benzo[a]pyrene-DNA adducts in human lung. Carcinogenesis 12:1445-1449 (1991).
19. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus A-M, Petruzzelli S, Giuntini C, Bartsch H. An improved fluorimetric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 52:6248-6253 (1992).
20. Corley J, Hurtubise RJ, Bowman ED, Weston A. Solid matrix, room temperature phosphorescence identification and quantitation of the tetrahydrotetrols derived from the acid hydrolysis of benzo[a]pyrene-DNA adducts from human lung. Carcinogenesis 16:423-426 (1995).
21. Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol 4:364-368 (1991).
22. Foiles PG, Murphy SE, Peterson LA, Carmella SG, Hecht SS. DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens. Cancer Res 52(Suppl 9):2698s-2701s (1992).
23. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 14:151-154 (1993).
24. Degawa M, Stern SJ, Martin MV, Guengerich FP, Fu PP, Ilett KF, Kaderlik RK, Kadlubar FF. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 54:4915-4919 (1994).
25. Szyfter K, Hemminki K, Szyfter W, Szmeja Z, Banaszewski J, Yang K. Aromatic DNA adducts in larynx biopsies and leukocytes. Carcinogenesis 15:2195-2199 (1994).
26. 32P-Postlabelling analysis of aromatic DNA adducts in human oral mucosal cells. Carcinogenesis 7:1115-1120 (1986).
27. 32P-adduct assay. Carcinogenesis 9:2309-2313 (1988).
28. 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents. Carcinogenesis 10:1429-1434 (1989).
29. 32P postlabeling. Cancer Res 53:1522-1528 (1993).
30. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1:61-66 (1991).
31. Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-amino-biphenyl as a major adduct. Proc Natl Acad Sci USA 88:5350-5354 (1991).
32. Phillips DH, Hewer A. DNA adducts in human urinary bladder and other tissues. Environ Health Perspect 99:45-49 (1993).
33. Bosch FX, Muñoz N. Etiological factors on cervical cancer. In: Cancer Prevention: Vital Statistics to Intervention (Zatonski W, Boyle P, Tyczynsi J, eds). Warsaw:PA Interpress, 1990;114-121.
34. Simons AM, Phillips DH, Coleman DV. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ 306:1444-1448 (1993).
35. Phillips DH, Ni Shé M. DNA adducts in cervical tissue of smokers and non-smokers. Mutation Res 313:277-284 (1994).
36. 32P-postlabelling: a study of the relationship with smoking history and oral contraceptive use. Carcinogenesis 15:1097-1100 (1994).
37. El-Bayoumy K. Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5:585-590 (1992).
38. Biggs PJ, Warren W, Venitt S, Stratton MR. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8:275-283 (1993).
39. Palmer JR, Rosenberg L, Clarke EA, Stolley PD, Warshauer ME, Zauber AG, Shapiro S. Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol 134:1-13 (1991).
40. Morabia A, Bernstein M, Heritier S, Khatchatrian N. A population-based case-control of tobacco smoking and breast cancer. SER Abstracts. Am J Epidemiol 139:S28 (1994).
41. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233-238 (1995).
42. Dyke GW, Craven JL, Hall R, Garner RC. Smoking-related DNA adducts in human gastric cancers. Int J Cancer 52:847-850 (1992).
43. Daling JR, Sherman KJ, Hislop TG, Maden C, Mandelson MT, Beckmann AM, Weiss NS. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135:180-189 (1992).
44. 32P-Postlabeling analysis of DNA adducts in human sperm cells from smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 2:581-585 (1993).
45. Little J, Vainio H. Mutagenic lifestyles? A review of evidence of associations between germ-cell mutations in humans and smoking, alcohol consumption and use of 'recreational' drugs. Mutat Res 313:131-151 (1994).
46. 32P-postlabeling analysis. Carcinogenesis 11:205-211 (1990).
47. van Maanen JMS, Maas LM, Hageman G, Kleinjans JCS, van Agen B. DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers. Environ Mol Mutagenesis 24:46-50 (1994).
48. 32P-postlabelling assay. Carcinogenesis 12:503-508 (1991).
49. Santella RM, Grinberg-Funes RA, Young TL, Dickey C, Singh VN, Wang LW, Perera FP. Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. Carcinogenesis 13:2041-2045 (1992).
50. van Schooten FJ, Hillebrand MJX, van Leeuwen FE, van Zandwijk N, Jansen HM, den Engelse L, Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis 13:987-993 (1992).
51. Rothman N, Correa-Villaseñor A, Ford DP, Poirier MC, Haas R, Hansen JA, O'Toole T, Strickland PT. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol Biomarkers Prev 2:341-347 (1993).
52. Holz O, Krause T, Rüdiger HW. Differences in DNA adduct formation between monocytes and lymphocytes after in vitro incubation with benz[a]pyrene. Carcinogenesis 12:2181-2183 (1991).
53. Mustonen R, Hemminki K. 7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis 13:1951-1955 (1992).
54. Everson RB, Randerath E, Santella RM, Cefalo RC, Avitts TA, Randerath K. Detection of smoking-related covalent DNA adducts in human placenta. Science 231:54-57 (1986).
55. Manchester DK, Bowman ED, Parker NB, Caporaso NE, Weston A. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Cancer Res 52:1499-1503 (1992).